| Ramanpreet Kaur Sandhu, FNP-C | |
|
6069 N 1st St Ste 103, Fresno, CA 93710 | |
| (559) 431-8900 | |
| Not Available |
| Full Name | Ramanpreet Kaur Sandhu |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 6069 N 1st St Ste 103, Fresno, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023520673 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 95007765 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ramanpreet Kaur Sandhu, FNP-C 6069 N 1st St Ste 103, Fresno, CA 93710-5467 Ph: (559) 431-8900 | Ramanpreet Kaur Sandhu, FNP-C 6069 N 1st St Ste 103, Fresno, CA 93710 Ph: (559) 431-8900 |
News Archive
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Georgia Health Sciences University is enrolling patients in a federally funded study to determine if a lower blood pressure reduces the progression of kidney disease.
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
IMS Health today reported 5.1 percent growth in 2009 U.S. sales of ethical pharmaceuticals and insulins through retail and non-retail channels, reaching $300.3 billion, compared with growth of 1.8 percent in 2008.
In 2008, researchers at the Perelman School of Medicine at the University of Pennsylvania showed that mutations in two proteins associated with familial Alzheimer's disease (FAD) disrupt the flow of calcium ions within neurons.
› Verified 6 days ago
Ms. Sheila Orallo Mallory, N. P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1867 E Fir Ave Ste 104, Fresno, CA 93720 Phone: 559-325-5876 Fax: 559-325-5838 | |
Gretchen Nelson, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1105 E Spruce Ave Ste 203, Fresno, CA 93720 Phone: 559-450-7272 Fax: 559-450-7276 | |
Marlene Solomon Lim, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5755 E Kings Canyon Rd, Suite 104, Fresno, CA 93727 Phone: 559-255-7777 Fax: 559-454-1091 | |
Ms. Yolanda Mata, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 257 N Dewitt Ave, Fresno, CA 93727 Phone: 559-255-1373 | |
Tamara Carpenter, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Shalvi Shaili, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5860 E Byrd Ave, Fresno, CA 93727 Phone: 510-334-9295 | |
Natalie Betancur, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 645 S Minnewawa Ave, Fresno, CA 93727 Phone: 800-492-4227 |